AOT 2026 | Professor Xiaodong Mo: Clinical Positioning and Key Decision-Making Considerations for Allogeneic Hematopoietic Stem Cell Transplantation in Non-Hodgkin Lymphoma
To comprehensively improve public health and strengthen strategies for the prevention and treatment of major diseases, medical innovation and international collaboration have become key drivers of clinical progress. Against this backdrop, the 2026 Beijing International Hematopoietic Stem Cell Transplantation Conference (AOT) was successfully held in Beijing from April 24 to 25, 2026. Organized by the Hematology Branch of the China International Exchange and Promotive Association for Medical and Health Care and hosted by the National Clinical Research Center for Hematologic Diseases and the Peking University Institute of Hematology, this year’s conference centered on the theme “The Art of Transplantation.” The meeting brought together leading hematology experts from around the world to discuss cutting-edge innovations and future directions in hematopoietic stem cell transplantation.
2nd Peking University Urology Academic Forum | Professor Chaohui Gu: Umbilical Artery Ligament Suspension—A New Breakthrough for Immediate Urinary Continence After Radical Prostatectomy
At the 2nd Peking University Urology Academic Forum and the 80th Anniversary Celebration of the Department of Urology at Peking University First Hospital, Oncology Frontier – UroStream interviewed Professor Chaohui Gu from the Department of Urology, The First Affiliated Hospital of Zhengzhou University.
2nd Peking University Urology Academic Forum | Professor Wei Zhu: FANS Technology Revolutionizes Flexible Ureteroscopic Lithotripsy Through Clinician–Engineer Innovation
Flexible ureteroscopic lithotripsy is an important treatment modality for upper urinary tract stones. However, conventional procedures are associated with several limitations, including low stone-free rates, elevated intrarenal pressure during surgery, and increased risks of postoperative infection and ureteral stricture.
International Perspectives from EBMT | Professor Florent Malard: New Frontiers in Microbiome-Based Therapy for the Treatment and Prevention of Graft-versus-Host Disease
Graft-versus-host disease (GVHD) remains one of the most severe complications following hematopoietic stem cell transplantation. Among its manifestations, acute gastrointestinal GVHD is particularly challenging to manage. Despite standard therapies, a substantial proportion of patients fail treatment, and no approved therapeutic options currently exist for those with refractory disease, representing a major unmet medical need.
Professor Liqun Zou: Advances in the Diagnosis and Treatment of Peripheral T-Cell Lymphoma | 2026 CACA Western Integrated Oncology Conference
Amid the vibrant renewal of spring, the 2026 CACA Western Integrated Oncology Conference was grandly convened in Chengdu, Sichuan. The meeting brought together leading oncology experts from across China to explore the frontiers of precision oncology and advance integrated, whole-course cancer care.
Professor Qingyuan Zhang: From Strategic Deployment of Novel Therapies to Integrated Care—Exploring New Survival Pathways in R/R DLBCL | 2026 CACA Western Integrated Oncology Conference
Amid the vibrant renewal of spring, the 2026 CACA Western Integrated Oncology Conference was grandly convened in Chengdu, Sichuan. The meeting brought together leading oncology experts from across China to explore the frontiers of precision oncology and advance integrated, whole-course cancer care.
